期刊文献+

柠檬酸与乙酸酐混合溶液中分光光度法测定盐酸西布曲明 被引量:2

Spectrophotometric Determination of Sibutramine Hydrochloride in Citric Acid-Acetic Anhydride Mixed Solution
下载PDF
导出
摘要 柠檬酸和乙酸酐混合溶液与盐酸西布曲明在80℃的水浴中加热30 min,反应后使溶液呈紫黑色,在330 nm波长处吸收最大,据此建立测定盐酸西布曲明的分光光度法。盐酸西布曲明的质量浓度在0.17~18.5 mg.L-1范围内遵守比耳定律,相关系数为0.998 9,表观摩尔吸光率为8.16×104L.mol-1.cm-1,检出限为61.5μg.L-1。用于曲美胶囊中盐酸西布曲明的测定,测定结果与高效液相色谱法结果相符,其相对标准偏差(n=6)值均小于0.5%。 It was found that when sibutramine hydrochloride(abbreviated as SBTM) was reacted with the mixed solution of citric acid and acetic anhydride at 80 ℃ in water bath,a purple black solution was obtained.The absorption maxima of the solution was found at 330 nm,and Beer′s law was obeyed in the range from 0.17 mg·L-1 to 18.5 mg·L-1(r=0.998 9),with its detection limit of 61.5 μg·L-1.Molar absorptivity of the colored solution was found to be 8.16×104L·mol-1·cm-1.The proposed method has been applied to the analysi...
作者 秦宗会 谭蓉
出处 《理化检验(化学分册)》 CAS CSCD 北大核心 2007年第12期1045-1047,共3页 Physical Testing and Chemical Analysis(Part B:Chemical Analysis)
基金 重庆市高等学校优秀中青年骨干教师资助计划[渝教人(2005)2号] 长江师范学院科研(No:07Jkg50)资助
关键词 分光光度法 盐酸西布曲明 柠檬酸 乙酸酐 Spectrophotometry Sibutramine hydrochloride Citric acid Acetic anhydride
  • 相关文献

参考文献5

二级参考文献22

  • 1Yang JW. ( Sepracor Inc. ) Methods and composition for treating depression and other disorders using optically pure ( + ) sibutramine.PCT Int. Appl. WO 9400047 ( Cl. A51K31/45) ,06 Jan 1994,US Appl. 903034,23 Jun 1992 ;40pp.
  • 2Yang JW. ( Sepracor Inc. ) Pharnlaceutical compositions for treating depression and other cerebral disorders containing optically pure( - )sibutramine. PCT Int. Appl. WO 9400114( Cl. A61 K31/135 ) ,06 Jan1994, US Appl. 903040,23 Jun 1992 ;40pp.
  • 3Radhakrishna T, Narayana CL, Rao DS,et al. LC method for the determination of assay and purity of sibutramine hydrochlorlde and its enantiomers by chiral chromatography. J Pharm Biomed Anal ,2000,22 :627.
  • 4Lelievnre F, Gareil P. Selectivity in capillary electrophoresis : application to chiral separations with cyclodextrins. Anal Chem, 1997,69:385.
  • 5Wren SAC, Rowe RC. Theoretieal aspects of chiral separation in capillary electrophoresis Ⅱ. The role of organic solvent. J Chromatogr,1992,609:363.
  • 6.中国药典.2000年版.二部[S].,2000.附录:32.
  • 7Garratt CJ,Hind ID,Haddock RE.Single/repeat dose kinetics ofsibutramine metabolites in obeses subjects (abstract)[].Journal of Clinical Pharmacology.1995
  • 8Drouin P,Hanotin C,Courciers,et al.A dose-ranging study efficacy andtolerability of sibutramine in weight loss[].Int J Ohes.1994
  • 9Study number SB 1049,Federal Drug Administration New Drug Approvalpackge [on-line]. http://w.w.w.fda gov cder /foi /ida /index 97 htm . 1998
  • 10.Meridia (sibutramine hydrolride monohydrate)Product information knollpharmaceutical conpany[]..1997

共引文献44

同被引文献25

  • 1梁晓丽,车宁.盐酸西布曲明的研究现状[J].首都医药,2004,11(14):38-40. 被引量:6
  • 2秦宗会,谢兵.紫外光谱法测定曲美胶囊中的盐酸西布曲明[J].光谱实验室,2005,22(5):1025-1027. 被引量:9
  • 3秦宗会,谭蓉,蒲利军,江虹.刚果红褪色光度法测定盐酸西布曲明及作用机理研究[J].分析化学,2006,34(3):403-406. 被引量:16
  • 4秦宗会,刘艳,谭蓉,蒲利军.衍生荧光法测定盐酸西布曲明[J].分析试验室,2006,25(4):9-12. 被引量:4
  • 5LUQUE C A, REY J A. The discovery and status of sibutramine as an anti-obesity drug[J]. European Journal of Pharmacology, 2002, 440(2/ 3): 119-128.
  • 6TALLET A J, BLUNDELL J E, RODGERS R J. Sibutramine-induced anorexia: Potent, dose-dependent and behaviourally-selective profile in male rats[J]. Behavioural Brain Research, 2009, 198(2): 359-365.
  • 7ELFHAG K, ROSSNER S, BARKELING B, et al. Sibutramine treatment in obesity: initial eating behaviourin relation to weight loss results and changes in mood[J]. Pharmacological Research, 2005, 51 (2): 159-163.
  • 8KIORTSIS D N, TSOULI S, FILIPPATOS T D, et al. Effects of sibutramine and orlistat on mood inobese and overweight subjects: a randomised study[J]. Nutrition, Metabolism and Cardiovascular 2008, 18(3): 207-210.
  • 9MANNUCCI E, DICEMBRINI I, ROTELLA F, et al. Orlistat and sibutramine beyond weight loss[J]. Nutrition, Metabolism & Cardiovascular Diseases, 2008,18(5): 342-348.
  • 10LUQUE C A, REY J A. S ibulramine: a serotonin-norepinephrine reuptakeinhibitorfor the treatment of obesity[J]. Ann Pharmacother, 1999, 33(9): 968-978.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部